top border
top border
Featured Programs

MONALEESA-7 Trial in Premenopausal HR+ Breast Cancer
As we’ve now headed into 2018, it’s a great time to reflect on the important advances that continue to shape the way we treat our patients.

In this OncLive Peer Exchange, Adam Brufsky, MD, PhD; Francisco Esteva, MD, PhD; Komal Jhaveri, MD, FACP; Hope S. Rugo, MD; Lee Schwartzberg, MD, FACP, provide insight on the MONALEESA-7 trial in premenopausal HR-positive breast cancer.
View Now

Classification of Triple Negative Breast Cancer
Aditya Bardia, MD, MPH, Claudine Isaacs, MD, Joyce O'Shaughnessy, MD, Tiffany Traina, MD, discuss recent progress surrounding the identification of triple-negative breast cancer subgroups, promising novel approaches to treatment, and refinement of chemotherapy use.
View Now

Featured Video
Immunotherapy in the Treatment of Follicular Lymphoma
Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

Gina Columbus

Gina Columbus highlights the latest news in oncology in this week's OncLive News Network.

Publication Bottom Border
Border Publication
x